📊 Analyst Consensus & Targets
- Analyst Rating: Strong Buy
- Price Target: $377.72
- Sector: Healthcare – Medical Devices
💡 The Growth Thesis
Strong Buy Consensus: Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. Analysts project a 32.9% potential upside. Currently trading at a Forward P/E of 45.961174.